Osteoporosis, Postmenopausal
"Osteoporosis, Postmenopausal" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Metabolic disorder associated with fractures of the femoral neck, vertebrae, and distal forearm. It occurs commonly in women within 15-20 years after menopause, and is caused by factors associated with menopause including estrogen deficiency.
| Descriptor ID |
D015663
|
| MeSH Number(s) |
C05.116.198.579.610 C18.452.104.579.610
|
| Concept/Terms |
Osteoporosis, Postmenopausal- Osteoporosis, Postmenopausal
- Perimenopausal Bone Loss
- Bone Loss, Postmenopausal
- Bone Losses, Postmenopausal
- Postmenopausal Bone Losses
- Osteoporosis, Post-Menopausal
- Osteoporoses, Post-Menopausal
- Osteoporosis, Post Menopausal
- Post-Menopausal Osteoporoses
- Post-Menopausal Osteoporosis
- Postmenopausal Osteoporosis
- Osteoporoses, Postmenopausal
- Postmenopausal Osteoporoses
- Bone Loss, Perimenopausal
- Bone Losses, Perimenopausal
- Perimenopausal Bone Losses
- Postmenopausal Bone Loss
|
Below are MeSH descriptors whose meaning is more general than "Osteoporosis, Postmenopausal".
Below are MeSH descriptors whose meaning is more specific than "Osteoporosis, Postmenopausal".
This graph shows the total number of publications written about "Osteoporosis, Postmenopausal" by people in this website by year, and whether "Osteoporosis, Postmenopausal" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 1 | 2 |
| 2002 | 0 | 2 | 2 |
| 2006 | 0 | 1 | 1 |
| 2009 | 2 | 1 | 3 |
| 2010 | 1 | 0 | 1 |
| 2011 | 1 | 0 | 1 |
| 2017 | 1 | 0 | 1 |
| 2018 | 1 | 0 | 1 |
| 2021 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Osteoporosis, Postmenopausal" by people in Profiles.
-
Vertebral fractures are increased in rheumatoid arthritis despite recent therapeutic advances: a case-control study. Osteoporos Int. 2021 Jul; 32(7):1333-1342.
-
Assessment of patient-reported outcomes (PROs): treatment satisfaction, medication adherence, and quality of life (QoL) and the associated factors in postmenopausal osteoporosis (PMO) patients in Korea. J Bone Miner Metab. 2019 May; 37(3):563-572.
-
Dietary Inflammatory Index, Bone Mineral Density, and Risk of Fracture in Postmenopausal Women: Results From the Women's Health Initiative. J Bone Miner Res. 2017 May; 32(5):1136-1146.
-
Bisphosphonate-related osteonecrosis of jaws in 3 osteoporotic patients with history of oral bisphosphonate use treated with single yearly zoledronic acid infusion. J Oral Maxillofac Surg. 2012 Feb; 70(2):325-30.
-
Parathyroid hormone-related protein for the treatment of postmenopausal osteoporosis: defining the maximal tolerable dose. J Clin Endocrinol Metab. 2010 Mar; 95(3):1279-87.
-
The association between onion consumption and bone density in perimenopausal and postmenopausal non-Hispanic white women 50 years and older. Menopause. 2009 Jul-Aug; 16(4):756-9.
-
The prevalence of significant left-right hip bone mineral density differences among black and white women. Osteoporos Int. 2009 Dec; 20(12):2079-85.
-
Compliance with osteoporosis treatment guidelines in postmenopausal women. Ann Pharmacother. 2009 Feb; 43(2):242-50.
-
FokI polymorphism of the vitamin D receptor gene correlates with parameters of bone mass and turnover in a female population of the Italian island of Lampedusa. Calcif Tissue Int. 2007 Jan; 80(1):15-20.
-
Postmenopausal hormone therapy: have HERS2 and WHI given us any new information? J S C Med Assoc. 2002 Dec; 98(8):299-304.